| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Jonathan Peter Mason CEO | LSE Exchange | G23969101 CUSIP |
| GB Country | 10,489 Employees | 16 Apr 2026 Last Dividend | - Last Split | - IPO Date |
ConvaTec Group PLC is a global entity specializing in the innovation, production, and marketing of medical products, services, and technologies. The company operates across Europe, North America, and other international markets. It focuses on offering solutions for the management of acute and chronic wounds, ostomy care, continence care, critical care, and infusion care needs. Founded in 1978, ConvaTec is dedicated to enhancing the lives of people with medical conditions that require specialized care, by providing advanced medical products. Headquartered in London, United Kingdom, the company reaches its customers through direct sales and a network of distributors and wholesalers, catering to pharmacies, hospitals, and a variety of healthcare providers.
These products are designed for the management of acute and chronic wounds caused by conditions such as diabetes, as well as wounds resulting from traumatic injuries and burns. They support the healing process, offering solutions for both healthcare providers and patients managing wound care.
ConvaTec provides a comprehensive range of devices, accessories, and services for individuals with a stoma, which may be due to colorectal cancer, inflammatory bowel disease, or bladder cancer. These solutions aim to improve the quality of life for people living with a stoma by addressing their specific needs.
Targeting individuals with urinary continence issues stemming from spinal cord injuries, multiple sclerosis, spina bifida, and other causes, these products and services offer support and solutions to manage continence, enhancing the users' independence and confidence.
These are utilized in intensive care units and hospital settings, offering essential support for critically ill patients. ConvaTec’s critical care range includes devices and products that cater to the specific needs of patients requiring intensive medical attention.
Comprising disposable infusion sets designed either for insulin pumps used by diabetes patients or for pumps facilitating continuous subcutaneous infusion treatments for conditions like Parkinson’s disease, these solutions demonstrate ConvaTec’s commitment to improving the management of chronic conditions through innovation.